Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VascDiab metformin study in ANCA-associated vasculitis
ACTRN12619000486123Phase 3Not yet recruiting
- Sponsor
- North Shore University Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) (2 arms), sponsored by North Shore University Hospital. Primary endpoints: Feasibility of recruitment, Tolerability of metformin and 1 more. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on ACTRN12619000486123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000486123.